All Stories

  1. The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries

    Article • Global Social Policy, October 2017, SAGE Publications

    Deborah Gleeson

  2. Why Packaging Is Commercially Vital for Tobacco Corporations

    Article • Asia Pacific Journal of Public Health, March 2017, SAGE Publications

    Deborah Gleeson

  3. The Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam

    Article • Global Public Health, November 2016, Taylor & Francis

    Deborah Gleeson

  4. Advancing Public Health on the Changing Global Trade and Investment Agenda Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?"

    Article • International Journal of Health Policy and Management, September 2016, International Society for Phytocosmetic Scicences

    Deborah Gleeson

  5. The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia

    Article • International Journal of Health Services, August 2016, SAGE Publications

    Deborah Gleeson

  6. Is health impact assessment useful in the context of trade negotiations? A case study of the Trans Pacific Partnership Agreement

    Article • BMJ Open, April 2016, BMJ

    Deborah Gleeson

  7. Shaping the discourse: What has the food industry been lobbying for in the Trans Pacific Partnership trade agreement and what are the implications for dietary health?

    Article • Critical Public Health, February 2016, Taylor & Francis

    Deborah Gleeson, Ashley Schram

  8. To what extent does a tobacco carve-out protect public health in the Trans-Pacific Partnership Agreement?

    Article • Public Health Research & Practice, January 2016, The Sax Institutute

    Deborah Gleeson

  9. Can learning sets help policy managers with their wicked problems?

    Article • Health Services Management Research, November 2015, SAGE Publications

    Deborah Gleeson

  10. Treating trade: the case for clinical engagement with regional trade agreements

    Article • The Lancet Diabetes & Endocrinology, June 2015, Elsevier

    Deborah Gleeson

  11. Costs to Australian taxpayers of pharmaceutical monopolies and proposals to extend them in the Trans-Pacific Partnership Agreement

    Article • The Medical Journal of Australia, April 2015, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Deborah Gleeson

  12. Patently obvious: a public health analysis of pharmaceutical industry statements on the Trans-Pacific Partnership international trade agreement

    Article • Critical Public Health, March 2015, Taylor & Francis

    Deborah Gleeson

  13. What doctors should know about the Trans-Pacific Partnership Agreement

    Article • The Medical Journal of Australia, March 2015, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Deborah Gleeson

  14. Call for transparency in new generation trade deals

    Article • The Lancet, February 2015, Elsevier

    Deborah Gleeson

  15. Will the next generation of preferential trade and investment agreements undermine prevention of noncommunicable diseases? A prospective policy analysis of the Trans Pacific Partnership Agreement

    Article • Health Policy, January 2015, Elsevier

    Deborah Gleeson, Ashley Schram

  16. Reply by authors

    Article • Health Policy, June 2014, Elsevier

    Ruth Lopert, Deborah Gleeson

  17. Retaining our right to regulate alcohol warnings

    Article • The Medical Journal of Australia, October 2013, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Deborah Gleeson

  18. How the Trans Pacific Partnership Agreement could undermine PHARMAC and threaten access to affordable medicines and health equity in New Zealand

    Article • Health Policy, October 2013, Elsevier

    Ruth Lopert, Deborah Gleeson

  19. Emerging threats to public health from regional trade agreements

    Article • The Lancet, April 2013, Elsevier

    Deborah Gleeson

  20. The High Price of “Free” Trade: U.S. Trade Agreements and Access to Medicines

    Article • The Journal of Law Medicine & Ethics, March 2013, Wiley

    Deborah Gleeson

  21. A new generation of trade policy: potential risks to diet-related health from the trans pacific partnership agreement

    Article • Globalization and Health, January 2013, Springer Science + Business Media

    Deborah Gleeson

  22. Challenges to Australia's national health policy from trade and investment agreements

    Article • The Medical Journal of Australia, March 2012, Australasian Medical Publishing Co. Pty Ltd. (AMPCo)

    Deborah Gleeson

  23. Strengthening public health engagement in trade policy: PHAA's policy onTrade Agreements and Health

    Article • Australian and New Zealand Journal of Public Health, February 2012, Wiley

    Deborah Gleeson

  24. The Health of Nations: Towards a New Political Economy

    Article • Australian Health Review, January 2012, CSIRO Publishing

    Deborah Gleeson

  25. A System for Program Evaluation in Community Health

    Article • Australian Journal of Primary Health, January 1999, CSIRO Publishing

    Deborah Gleeson

  26. How the transnational pharmaceutical industry pursues its interests through international trade and investment agreements: a case study of the Trans Pacific Partnership

    Article • Edward Elgar Publishing

    Deborah Gleeson

  27. How the Transnational Pharmaceutical Industry Pursues its Interests Through International Trade and Investment Agreements: A Case Study of the Trans Pacific Partnership

    Article • SSRN Electronic Journal, Elsevier

    Deborah Gleeson

  28. Pharma's Next Frontier? New Threats to Public Health in the Regional Comprehensive Economic Partnership Agreement

    Article • SSRN Electronic Journal, Elsevier

    Deborah Gleeson, Belinda Townsend